Availability of Mifepristone and Misoprostol in Oregon Pharmacies: A Comparison by Rural and Urban Status.
Abortion
mifepristone
misoprostol
pharmacy
Journal
Contraception
ISSN: 1879-0518
Titre abrégé: Contraception
Pays: United States
ID NLM: 0234361
Informations de publication
Date de publication:
17 May 2024
17 May 2024
Historique:
received:
17
01
2024
revised:
17
03
2024
accepted:
14
05
2024
medline:
20
5
2024
pubmed:
20
5
2024
entrez:
19
5
2024
Statut:
aheadofprint
Résumé
To evaluate the availability of mifepristone and misoprostol at pharmacies in a state with protective abortion legislation and variation in access by rurality. Using a secret shopper survey, researchers attempted to contact all community pharmacies in Oregon and evaluate their mifepristone and misoprostol provision. Among the 444 pharmacies surveyed, mifepristone was planned at 19.2%. Misoprostol was available at 77.5%, but stocking issues and medication ordering impact access, without significant difference by rurality. Pharmacy engagement and support is key to increasing access to these essential medicines, which may be improved through education and referral programs.
Identifiants
pubmed: 38763275
pii: S0010-7824(24)00163-X
doi: 10.1016/j.contraception.2024.110491
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110491Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.